Novo Nordisk Hands Over Parkinson’s Therapy to AI Startup
· Financial Post
(Bloomberg) — Novo Nordisk A/S agreed to hand over an experimental therapy for Parkinson’s disease to a Mark Zuckerberg-backed AI startup to potentially speed its development. Read More
Visit sportbet.reviews for more information.